GPCRVSONCO• 6 Months (Normalized)
GPCR vs ONCO (Structure Therapeutics Inc. vs Onconetix Inc.)
Showing Closing Date Range from Mar, 20 to Sep, 16, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GPCR Performance $35.5
-26.94%
Structure Therapeutics Inc.
Normalized Baseline0.00%
ONCO Performance $0.66
-97.86%
Onconetix Inc.
Normalized Baseline0.00%
Alpha Spread Margin GPCR LEADS
+70.92%
GPCR outperforming by 70.92%
GPCRONCO
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GPCR ONCO
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(124 dates)
| Date | GPCR Price | GPCR Gain (%) | ONCO Price | ONCO Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 16, 2026 | $35.50 | -26.94% | $0.66 | -97.86% | +70.92% |
| Sep 15, 2026 | $38.95 | -19.84% | $0.65 | -97.92% | +78.08% |
| Sep 14, 2026 | $38.44 | -20.89% | $0.64 | -97.95% | +77.06% |
| Sep 11, 2026 | $38.66 | -20.44% | $0.76 | -97.56% | +77.12% |
| Sep 10, 2026 | $39.55 | -18.60% | $0.78 | -97.48% | +78.88% |
| Sep 09, 2026 | $41.23 | -15.15% | $0.81 | -97.38% | +82.23% |
| Sep 08, 2026 | $40.38 | -16.90% | $0.84 | -97.29% | +80.39% |
| Sep 04, 2026 | $47.34 | -2.57% | $1.02 | -96.71% | +94.14% |
| Sep 03, 2026 | $47.34 | -2.57% | $0.74 | -97.62% | +95.05% |
| Sep 02, 2026 | $47.80 | -1.63% | $0.67 | -97.83% | +96.20% |
| Sep 01, 2026 | $47.13 | -3.00% | $0.65 | -97.89% | +94.89% |
| Aug 31, 2026 | $45.91 | -5.52% | $0.63 | -97.98% | +92.46% |
| Aug 28, 2026 | $47.37 | -2.51% | $0.61 | -98.03% | +95.52% |
| Aug 27, 2026 | $49.22 | +1.30% | $0.63 | -97.96% | +99.26% |
| Aug 26, 2026 | $49.35 | +1.56% | $0.64 | -97.93% | +99.49% |
Page 1 of 9